Clinical Trial Update: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 open-label study assessing levetiracetam monotherapy in patients with newly diagnosed focal epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsy, Partial Onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2014-10-13